- $4.59bn
- $3.84bn
- $1.56bn
- 86
- 67
- 88
- 95
Annual income statement for Alkermes, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,039 | 1,174 | 1,112 | 1,663 | 1,558 |
| Cost of Revenue | |||||
| Gross Profit | 860 | 976 | 894 | 1,410 | 1,312 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1,151 | 1,206 | 1,118 | 1,249 | 1,137 |
| Operating Profit | -112 | -32.3 | -6.09 | 414 | 421 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -96.5 | -39.3 | -31.1 | 422 | 444 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -111 | -48.2 | -33.2 | 519 | 372 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -111 | -48.2 | -158 | 356 | 367 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -111 | -48.2 | -158 | 356 | 367 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.698 | -0.287 | -0.2 | 3.09 | 2.2 |